2427. Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
作者: Jawad H Butt.;Pooja Dewan.;Béla Merkely.;Jan Belohlávek.;Jarosław Drożdż.;Masafumi Kitakaze.;Silvio E Inzucchi.;Mikhail N Kosiborod.;Felipe A Martinez.;Sergey Tereshchenko.;Piotr Ponikowski.;Olof Bengtsson.;Daniel Lindholm.;Anna Maria Langkilde.;Morten Schou.;Mikaela Sjöstrand.;Scott D Solomon.;Marc S Sabatine.;Chern-En Chiang.;Kieran F Docherty.;Pardeep S Jhund.;Lars Køber.;John J V McMurray.
来源: Ann Intern Med. 2022年175卷6期820-830页
Frailty may modify the risk-benefit profile of certain treatments, and frail patients may have reduced tolerance to treatments.
2429. International Validation of the Canadian Syncope Risk Score : A Cohort Study.
作者: Tobias Zimmermann.;Jeanne du Fay de Lavallaz.;Thomas Nestelberger.;Danielle M Gualandro.;Pedro Lopez-Ayala.;Patrick Badertscher.;Velina Widmer.;Samyut Shrestha.;Ivo Strebel.;Noemi Glarner.;Matthias Diebold.;Òscar Miró.;Michael Christ.;Louise Cullen.;Martin Than.;F Javier Martin-Sanchez.;Salvatore Di Somma.;W Frank Peacock.;Dagmar I Keller.;Murat Bilici.;Juan Pablo Costabel.;Michael Kühne.;Tobias Breidthardt.;Venkatesh Thiruganasambandamoorthy.;Christian Mueller.; .;Maria Belkin.;Kathrin Leu.;Jens Lohrmann.;Jasper Boeddinghaus.;Raphael Twerenbold.;Luca Koechlin.;Joan E Walter.;Melissa Amrein.;Desiree Wussler.;Michael Freese.;Christian Puelacher.;Damian Kawecki.;Beata Morawiec.;Emilio Salgado.;Gemma Martinez-Nadal.;Carolina Isabel Fuenzalida Inostroza.;José Bustamante Mandrión.;Imke Poepping.;Katharina Rentsch.;Arnold von Eckardstein.;Andreas Buser.;Jaimi Greenslade.;Tobias Reichlin.;Franz Bürgler.
来源: Ann Intern Med. 2022年175卷6期783-794页
The Canadian Syncope Risk Score (CSRS) was developed to predict 30-day serious outcomes not evident during emergency department (ED) evaluation.
|